Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1989-01-18
1992-01-07
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536103, 514929, 514964, 514778, 514781, 514356, 424488, 424486, 424457, 424468, A61K 31455, C07D21190
Patent
active
050792377
ABSTRACT:
There is described a new inclusion complex of nicardipine or its hydrochloride with beta-cyclohdextrin, which is prepared by admixing nicardipine or its hydrochloride with beta-cyclodextrin in a molar ratio of the compounds 1:0.9-1.1 under stirring at a temperature from about room temperature to the boiling temperature of the reaction mixture in an aqueous or ethanolic medium, cooling the reaction mixture to 0.degree. to 5.degree. C. and isolating the desired complex.
The inclusion complex of nicardipine or its hydrochloride posesses cerebrovascular-vasodilatory and coronary-vasodilatory properties, which are equally well expressed as those of nicardipine or its hydrochloride themselves, yet owing to the better solubility of the complex at a higher pH range, such as it exists e.g. in the intestinal tract, the manufacture of sustained release pharmaceutical forms is made possible, whereby a greater extent of dissolution of the active substance is provided also in the intestinal juice.
REFERENCES:
patent: 4383992 (1983-05-01), Lipari
patent: 4555504 (1985-11-01), Jones
patent: 4727064 (1988-02-01), Pitha
patent: 4826963 (1989-05-01), Stadler et al.
patent: 4869904 (1989-09-01), Uekama et al.
patent: 4952565 (1990-08-01), Zmitek et al.
Fairchild, Editor, Suspected Carcinogens, A Sourcebook of the Toxic Effects of Chemical Substances, Castle House Publications, Ltd, 1978, I.S.B. No.-7194-0000-7-printed in Great Britain by Billing & Sons Limited, Guildford, p. 191, item TZ29750.
E. Fenyvesi et al., "Properties of Cyclodextrin Polymer as a Tablething Aid", Chem. Pharm. Bull. 32(2), 665-669 (1984).
M. Kurozumi et al, "Inclusion Compounds of Non-Steroidal Antiinflammatory and Other Slightly Water Soluble Drugs with .alpha.- and .beta.-Cyclohdextrins in Powdered Form", Chem. Pharm. Bull. 23(12), 3062-3068 (1975).
Stadler-Szoke et al., "A Forecast for Application of Cyclodextrins in the Pharma-Industry", I. Int. Symp. on Cyclodextrins, Budapest, 30 Sep. -2 Oct. 1981, 5.2, p. 377.
Thuillez et al., "Nicardipine: Pharmacokinetics and Effects on Carotid and Brachial Blood Flows in Normal Volunteers", Br. J. Clin. Pharmac. (1984), 18, pp. 837-847.
Pitha et al., "Hydroxypropyl-.beta.-Cyclodextrin: Preparation and Characterization; Effects on Solubility of Drugs", Int. J. of Pharm. 29 (1986), pp. 73-82.
Budavari, Editor, The Merck Index, 11th ed. 1989, p. 1247, item 7869, published by Merck & Co., Inc., Rahway, N.J., U.S.A.
Uekama et al, "Ethylated .beta.-Cyclodextrins as Hydrophobic Drug Carriers: Sustained Release of Diltiazem in the Rat", Journal of Pharmaceutical Sciences, vol. 76, No. 8, Aug. 1987, pp. 660-661.
Hirayama et al, "Utilization of Diethyl-.beta.-Cyclodextrin as a Sustained-Release Carrier for Isosobide Dinitrate", Journal of Pharmaceutical Sciences, vol. 77, No. 3, Mar. 1988, pp. 233-236.
Horiuchi et al., "Slow-Release Characteristics of Diltiazem from Ethylated .beta.-Cyclodextrin Complexes", Journal of Pharmaceutical Sciences, vol. 79, No. 2, 1990, pp. 128-132.
Chemical Abstracts, vol. 101, Abstract 101:230946w, 1984.
Chemical Abstracts, vol. 110, abstract 110:101775b, Mar. 20, 1989.
Szejitli et al, "Synthesis and C-NMR Spectroscopy of Methylated Beta-Cyclodextrins", Starch Starke (1980), vol. 32, No. 5, pp. 165-169.
The Merck Index, 11th edition (1989), pp. 493-494, item 3120.
Szejtli, Cyclodextrin Technology, 1988 published by Kluever Academic Publishers, Boston, Mass., pp. 80-83.
Bukovec Peter
Cvelbar Polona
Huc Branko
Husu Breda
Jerala-Strukelj Zdenka
Griffin Ronald W.
LEK
LandOfFree
Inclusion complex of nicardipine or its hydrochloride with beta- does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inclusion complex of nicardipine or its hydrochloride with beta-, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inclusion complex of nicardipine or its hydrochloride with beta- will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-822675